Ikonisys, New Haven, Conn a provider of noninvasive, cell-based diagnostic solutions, has established a clinical lab registered with the Centers for Medicare and Medicaid Services under the CLIA provisions and licensed by the state of Connecticut.

The company’s tests aid in the early diagnosis of genetic disorders and cancer progression.

The lab will support proprietary and non-proprietary tests based on fluorescence in situ hybridization (FISH).

Its products include proprietary tests for circulating fetal cells and circulating tumor cells, and plans are under way to initiate clinical trials of its noninvasive oncoFISH® cervical cancer test. FISH-based lab testing and services are offered to medical providers lacking the internal resources for the specialized service.